Intravenous autologous bone marrow derived stem cells therapy for patients with acute ischemic stroke: A multi-institutional project "InVeST"

Active, not recruiting

Phase N/A Results N/A

Summary of Purpose

The project is a multi-centric initiative to study the safety, feasibility and efficacy of using intravenous autologous bone marrow mononuclear cells (BMMC) in patients with acute ischaemic stroke. This phase of study is visualized as phase 2 study and will aim to determine the dose response gradient of stem cell therapy and to explore if there is favorable risk to benefit ratio for stem cell therapy in patients with acute ischaemic stroke....

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 December 2010.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics



  • Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi

Trial Design

Randomized, parallel group, active controlled trial


  • Professor of Neurology, Room No- 704, C.N Centre, Department of Neurology, All India Institute of Medical Sciences,New Delhi, INDIA Tel:01126588979 Fax:011-26588979